A case of α-synuclein gene duplication presenting with head-shaking movements

Movement Disorders

Volumn 28, Issue 3, 2013, Pages 384-387

  Itokawa, Kaori ^a   Sekine, Takeshi ^c   Funayama, Manabu ^c,d   Tomiyama, Hiroyuki ^c   Fukui, Miki ^a   Yamamoto, Toshimasa ^a   Tamura, Naotoshi ^a   Matsuda, Hiroshi ^b   Hattori, Nobutaka ^c,d   Araki, Nobuo ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

Alpha synuclein gene duplication; Familial Parkinson's disease; Head shaking; Leucine rich repeat kinase 2

Indexed keywords

ALPHA SYNUCLEIN; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; LEUCINE RICH REPEAT KINASE 2; ROPINIROLE; ZONISAMIDE;

ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; GENE; GENE DOSAGE; GENE DUPLICATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HEAD MOVEMENT; HEAD SHAKING MOVEMENT; HOSPITAL DISCHARGE; HUMAN; MALE; PARKIN GENE; PARKINSON DISEASE; PEDIGREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREMOR;

ADULT; ALPHA-SYNUCLEIN; CEREBELLUM; CEREBRAL CORTEX; FAMILY HEALTH; FEMALE; GENE DUPLICATION; GENETIC TESTING; HEAD MOVEMENTS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MOVEMENT DISORDERS;

EID: 84875520893     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25243     Document Type: Article

References (22)

1. Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 1990;27:276-282.
2. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
3. Singleton AB, Farrer M, Johnson J, et al. α-Synuclein locus triplication cause Parkinson's disease. Science 2003;302:841.
4. Ikeuchi T, Kakita A, Shiga A, et al. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch Neurol 2008;65:514-519.
5. Muenter MD, Fomo LS, Homykiewicz O, et al. Hereditary form of parkinsonism-dementia. Ann Neurol 1998;43:768-781.
6. Nishioka K, Hayashi D, Farrer MJ, et al. Clinical heterogeneity of α-synuclein gene duplication in Parkinson's disease. Ann Neurol 2006;59:298-309.
7. Funayama M, Hasegawa K, Ohta E, et al. An LRRK2 mutation as a cause for the parkinsonism in the original Park8 family. Ann Neurol 2005;57:918-921.
8. Ishihara L, Gibson RA, Warren L, et al. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Mov Disord 2007;22:55-61.
9. Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009;41:1303-1307.
10. Dächsel JC, Mata IF, Ross OA, et al. Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2. Neurosci Lett 2006;410:80-84.
11. Funayama M, Li Y, Tomiyama H, et al. Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Neuroreport 2007;18:273-275.
12. Ross OA, Soto-Ortolaza AI, Heckman MG, et al. Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 2011;10:898-908.
13. Neychev VK, Fan X, Mitev VI, et al. The basal ganglia and cerebellum interact in the expression of dystonic movement. Brain 2008;131:2499-2509.
14. Argyelan M, Carbon M, Niethammer M, et al. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 2009;29:9740-9747.
15. Hirata Y, Matsuda H, Nemoto K, et al. Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett 2005;382:269-274.
16. Ibáñez P, Bonnet A-M, Débarges B, et al. Causal relation between besynuclein gene duplication and familial Parkinson's disease. Lancet 2004;364:1169-1171.
17. Chartier-Harlin MC, Kachergus J, Roumier C, et al. α-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004;364:1167-1169.
18. Uchiyama T, Ikeuchi T, Ouchi Y, et al. Prominent psychiatric symptoms and glucose hypometabolism in a family with a SNCA duplication. Neurology 2008;71:1289-1290.
19. Obi T, Nishioka K, Ross OA, et al. Clinicopathologic study of a SNCA gene duplication patient with Parkinson's disease and dementia. Neurology 2008;70:238-241.
20. Fuchs J, Nilsson C, Kachergus J, et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007;68:916-922.
21. Carballo-Carbajal I, Weber-Endress S, Rovelli G, et al. Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway. Cell Signal 2010;22:821-827.
22. Lin X, Parisiadou L, Gu XL, et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron 2009;64:807-827.